This summer, Texas Science students will travel the world to tackle challenges in public health, poverty and sustainability, thanks to UT Austin's inaugural President's Award for Global Learning.
Traumatic brain injuries (TBIs), caused by everything from falls to being hit by moving objects to car crashes, cause nearly a third of all injury-related deaths in the U.S. Millions of survivors struggle with impaired thinking and movement, personality changes or depression.
Livia Eberlin has been named a Moore Inventor Fellow. Photo courtesy of Moore Foundation.
A foundation that has set a goal this decade of identifying 50 inventors who will shape the next 50 years has added its second University of Texas at Austin faculty member to the list. The Gordon and Betty Moore Foundation announced Livia Eberlin, assistant professor in the Department of Chemistry, is one of this year's five Moore Inventor fellows.
Last year, Texas saw a particularly deadly flu season. Now, there is a new Federal Drug Administration-approved treatment, Xofluza, designed to catch the flu in its early stages and stop it from spreading. The drug is thanks in large part to professor emeritus Robert Krug's basic research, undertaken almost 40 years ago.
From "Fantastic Voyage" to "Despicable Me," shrink rays have been a science-fiction staple on screen. Now chemists at The University of Texas at Austin have developed a real shrink ray that can change the size and shape of a block of gel-like material while human or bacterial cells grow on it. This new tool holds promise for biomedical researchers...
An ultra-sensitive new method for identifying the series of amino acids in individual proteins (a.k.a. protein sequencing) can accelerate research on biomarkers for cancer and other diseases. Credit: David Steadman/University of Texas at Austin.
A team of researchers at The University of Texas at Austin has demonstrated a new way to sequence proteins that is much more sensitive than existing technology, identifying individual protein molecules rather than requiring millions of molecules at a time. The advance could have a major impact in biomedical research, making it easier to reveal new biomarkers for the diagnosis of cancer and other diseases, as well as enhance our understanding of how healthy cells function.
Four chemists (from left to right): Eric Anslyn, Jennifer Brodbelt, Hung-Wen (Ben) Liu, Jonathan Sessler receive major awards. Image Credit: University of Texas at Austin
Four UT Austin faculty members have won major awards for 2019 from the American Chemical Society (ACS) and the International Conference on Calixarenes for their contributions to an array of research areas.
Last year, University of Texas at Austin alumnus Michael Young won the Nobel Prize in Physiology or Medicine for discovering the molecular mechanism behind circadian rhythms. Circadian clocks are critical for the health of all living things, acting as the internal timekeepers in plants and animals that help to synchronize functions like eating and sleeping with our planet's daily rhythm of light and dark.
Updated on August 31, 2018: This release was updated to correct mistakes in descriptions of the way cancer cells develop drug resistance and the way that anti-cancer drug DCA affects the metabolism of cancer cells.
The chemical structure of C1, a drug combining two active elements: Doxorubicin (Dox), a powerful cancer chemotherapy agent that's been used for decades; and a dichloroacetic acid (DCA) subunit, which reverses a cell's metabolism to aerobic. Credit: University of Texas at Austin
A new drug lead shows promise that it could reduce the size of cancerous tumors much more effectively than current treatments.
Read our publication, The Texas Scientist, a digest covering the people and groundbreaking discoveries that make the College of Natural Sciences one of the most amazing and significant places on Earth.